BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33986486)

  • 1. Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT).
    Chan DL; Clarke SJ; Engel A; Diakos CI; Pavlakis N; Roach PJ; Bailey DL; Bauer J; Findlay M
    Eur J Clin Nutr; 2022 Jan; 76(1):143-149. PubMed ID: 33986486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
    Findlay M; White K; Brown C; Bauer JD
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed-Tomography Body Composition Analysis Complements Pre-Operative Nutrition Screening in Colorectal Cancer Patients on an Enhanced Recovery after Surgery Pathway.
    Klassen P; Baracos V; Gramlich L; Nelson G; Mazurak V; Martin L
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33291416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
    Zhang J; Kulkarni HR; Singh A; Niepsch K; Müller D; Baum RP
    J Nucl Med; 2019 Mar; 60(3):377-385. PubMed ID: 30115686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
    da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
    Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of
    Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
    J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
    Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
    Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
    Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
    Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients.
    Martin L; Gioulbasanis I; Senesse P; Baracos VE
    JPEN J Parenter Enteral Nutr; 2020 Feb; 44(2):227-238. PubMed ID: 31012128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully Automated Deep Learning Tool for Sarcopenia Assessment on CT: L1 Versus L3 Vertebral Level Muscle Measurements for Opportunistic Prediction of Adverse Clinical Outcomes.
    Pickhardt PJ; Perez AA; Garrett JW; Graffy PM; Zea R; Summers RM
    AJR Am J Roentgenol; 2022 Jan; 218(1):124-131. PubMed ID: 34406056
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
    Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
    J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
    Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor.
    Deng GM; Song HB; Du ZZ; Xue YW; Song HJ; Li YZ
    World J Gastroenterol; 2024 Feb; 30(8):863-880. PubMed ID: 38516238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
    Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
    Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
    Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost.
    Findlay M; Brown C; De Abreu Lourenço R; White K; Bauer J
    J Hum Nutr Diet; 2020 Dec; 33(6):811-821. PubMed ID: 32609428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
    Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
    J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review.
    Amini B; Boyle SP; Boutin RD; Lenchik L
    J Gerontol A Biol Sci Med Sci; 2019 Sep; 74(10):1671-1678. PubMed ID: 30726878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.